TELA Bio TELA
NASDAQ TELA
$0.65 +0.01 (+1.09%)
At close: Aug 21, 2026 · 4:00 PM EDT

TELA Bio (TELA) Tax Provisions (2025 - 2026)

TELA Bio (TELA) posted quarterly Tax Provisions of $60000.0 for Q1 2026, up 15.38% year-over-year from $52000.0 in Q1 2025, and up 5900.0% quarter-over-quarter from $1000.0 in Q4 2025.

TELA Bio (TELA) Tax Provisions (2025 - 2026) Analysis & Trends

TELA Bio's Tax Provisions history runs 2 years deep, the most recent figure standing at $60000.0 for Q1 2026.

  • In Q1 2026, Tax Provisions rose 15.38% year-over-year to $60000.0; the TTM figure through Mar 2026 stood at $94000.0 (changed N/A YoY), while the FY2025 annual figure was $86000.0, up 101.08% from the prior year.
  • Tax Provisions for Q1 2026 stood at $60000.0, up from $1000.0 in the prior quarter.
  • The five-year high for Tax Provisions was $60000.0 in Q1 2026, with the low at $1000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn 596.00 Mn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 288.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 575.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 155.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 278.40 Mn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 68.40 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 119.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -185.98 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 72.50 Mn
10 TELA Bio 35.91 Mn 5.49 Mn 13.94 Mn 60,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 60,000.00
Mar 31, 2026 60,000.00
Dec 31, 2025 1,000.00
Jun 30, 2025 33,000.00
Mar 31, 2025 52,000.00